VNRX Hisse Senedi Fiyat Grafiği
VNRX Finansal
VolitionRX Ltd
$2.49
6.86%
$0.16
Kapanışta: May 06, 16:00:00 GMT-4
$2.48
-0.4%
$-0.01
Sonrası Piyasa: May 06, 20:00:00 GMT-4
Geri
VolitionRX Ltd (VNRX) Finansal
Önemli İstatistikler
Önceki Kapanış
$2.33
Açılış fiyatı
$2.62
Günün Aralığı
$2.34 - $2.78
52 haftalık aralık
$0.1351 - $2.48
İşlem hacmi
1.0M
Ort.Hacim
8.5M
Dividend yield
--
EPS (TTM)
-0.22
Piyasa Değeri
$393.0M
VNRX nedir?
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. The company is headquartered in Henderson, Nevada and currently employs 85 full-time employees. The company went IPO on 2015-02-06. The firm is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
